Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Current Drug Delivery is Scopus-indexed (Q1, CiteScore 6.9), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by Bentham Science Publishers.
Checked against the index lists dated .
ISSN 1567-2018Verify ISSN ↗1875-5704Verify ISSN ↗
Publisher: Bentham Science Publishers
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmaceutical Science | 48 / 191 | 75th | Q1 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2004–present, best quartile Q1, CiteScore 6.9.
Current Drug Delivery is Q1 in Pharmaceutical Science (rank 48 of 191), by CiteScore 2025.
Current Drug Delivery is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 6.9, which places it in quartile Q1 at the 75th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.537, quartile Q2, with an H-index of 82.
Current Drug Delivery is published by Bentham Science Publishers. Its print ISSN is 1567-2018 and its online ISSN is 1875-5704.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Current Drug Delivery has an h-index of 83 and a 2-year mean of 2.88 citations per paper (OpenAlex). Its Scopus CiteScore is 6.9, quartile Q1. On 2-year citations it ranks #67 of 177 Scopus journals in Pharmaceutical Science.
Current Drug Delivery published 61 papers in 2025; its busiest recent year was 2021 with 169. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 99 research articles (2025–2026), authors are most often from China (34.8%), India (25.3%) and Saudi Arabia (7.7%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.